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Background: Nerve conduits provide a promising strategy for peripheral nerve injury
repair. However, the efficiency of nerve conduits to enhance nerve regeneration and
functional recovery is often inferior to that of autografts. Nerve conduits require
additional factors such as cell adhesion molecules and neurotrophic factors to
provide a more conducive microenvironment for nerve regeneration.
Methods: In the present study, poly{(lactic acid)-co-[(glycolic acid)-alt-(L-lysine)]}
(PLGL) was modified by grafting Gly-Arg-Gly-Asp-Gly (RGD peptide) and nerve
growth factor (NGF) for fabricating new PLGL-RGD-NGF nerve conduits to promote
nerve regeneration and functional recovery. PLGL-RGD-NGF nerve conduits were
tested in the rat sciatic nerve transection model. Rat sciatic nerves were cut off to
form a 10 mm defect and repaired with the nerve conduits. All of the 32 Wistar rats
were randomly divided into 4 groups: group PLGL-RGD-NGF, group PLGL-RGD,
group PLGL and group autograft. At 3 months after surgery, the regenerated rat
sciatic nerve was evaluated by footprint analysis, electrophysiology, and histologic
assessment. Experimental data were processed using the statistical software SPSS
10.0.
Results: The sciatic function index value of groups PLGL-RGD-NGF and autograft was
significantly higher than those of groups PLGL-RGD and PLGL. The nerve conduction
velocities of groups PLGL-RGD-NGF and autograft were significantly faster than those
of groups PLGL-RGD and PLGL. The regenerated nerves of groups PLGL-RGD-NGF
and autograft were more mature than those of groups PLGL-RGD and PLGL. There
was no significant difference between groups PLGL-RGD-NGF and autograft.
Conclusions: PLGL-RGD-NGF nerve conduits are more effective in regenerating
nerves than both PLGL-RGD nerve conduits and PLGL nerve conduits. The effect is as
good as that of an autograft. This work established the platform for further
development of the use of PLGL-RGD-NGF nerve conduits for clinical nerve repair.
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Nerve regeneration
Background
Peripheral nerve injuries are frequently caused by trauma and may lead to a significant
loss of sensory or motor functions. Numerous surgeries have been carried out each
year for nerve injury repairing. For short nerve injuries,direct end-to-end suturing
techniques are suggested. For severe nerve injuries, autologous nerve graft has been
the first choice. However, autologous nerve graft is limited by the availability of© 2012 Yan et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
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is to develop synthetic nerve conduits to bridge the gaps between the proximal and the
distal nerve stumps for promoting nerve regeneration. Studies over the past few dec-
ades have resulted in several clinically available nerve conduits, such as Neurotube
(polyglycolic acid, PGA, Synovis), Neurolac (poly-DL-lactide-caprolactone, PLCL, Poly-
ganics BV), NeuraGen (collagen type I, Integra NeuroSciences) and Neuro-Matrix/
Neuroflex (collagen type I, Collagen Matrix Inc) [3-11]. NeuraGen and Neuro-Matrix
/Neuroflex were fabricated out of collagen with favorable results in nerve repair
[12,13], but they are rather expensive and difficult to handle during suturing, further-
more, they only can bridge short defects because of their mechanical weakness [14]. Be-
cause of their good biodegradability, biocompatibility and mechanical properties,
Neurotube and Neurolac were approved by U.S. Food and Drug Administration (FDA)
and Conformit Europe (CE) for clinical nerve repair [1]. Nevertheless, current research
indicates that inert nerve conduits such as Neurotube and Neurolac cannot sustain op-
timal axonal growth, and specific modifications are required to permit successful nerve
regeneration and functional recovery [15]. It is believed that an ideal nerve conduit
should provide not only structural support for damaged nerves but also the neurotropic
and neurotrophic support for axonal regrowth. Numerous experiments indicated that,
after nerve injury, cell adhesion molecules and neurotrophic factors played very import-
ant roles in nerve regeneration and functional recovery [16-24].
Two major extracellular matrix (ECM) constituents, laminin and fibronectin, are
thought to promote cell adhesion. However, immune reactivity and protein denaturation
are concerned. To overcome the problem, the adhesive peptides, containing Arg-
Gly-Asp (RGD) sequence, have been tested as alternatives to native ECM proteins in the
past decades [25]. Adsorption of RGD peptides to polyesters surface was usually attempted,
but the retention time of the RGD peptides was too short for practical application.
Chemical modification might be an alternative approach, however, polyesters such as
PGA and PLCL lack functional groups to covalently bonding RGD peptides. We have
previously synthesized poly{(lactic acid)-co-[(glycolic acid)-alt-(L-lysine)]} (PLGL), which
incorporates free amines and can covalently bonding RGD peptides [26].
Nerve growth factor (NGF) is the most thoroughly characterized neurotrophic factor.
NGF can ensure the survival of the cell bodies and support the regeneration of the
axons toward specific target organs. For improvement of nerve conduits, a large num-
ber of studies have focused on the addition of NGF within the conduits [18-24]. Xu X
et al. reported the preparation of NGF-encapsulated microspheres for the delivery of
NGF. However, the organic solvents had unfavorable effects on the native structure of
NGF, resulting in the deactivation of NGF during the encapsulation procedure [27].
Chen P R et al. reported immobilizing NGF on gluataraldehyde cross-linking gelatin
membranes with carbodiimide for axonal regeneration. The NGF immobilized on the
membrane still kept bioactivity that could promote the neurite outgrowth of pheochro-
mocytoma (PC12) cell, but the gelatin membrane turned to more hydrophobic surface
after cross-linked by aldehyde group. This hydrophobic surface of the membranes
resulted in poor cell adhesion [28].
Since the carboxyl groups of PLGL-RGD molecules can also react with the amine
groups of NGF molecules in the presence of carbodiimide, we combined PLGL-RGD
with NGF to construct a double-functional PLGL-RGD-NGF nerve conduits. The
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duits to enhance nerve regeneration and functional recovery through the rat sciatic
nerve transection model.Methods
Materials
PLGL (Mw=1.5 × 105) was synthesized in our laboratory. Gly-Arg-Gly-Asp-Gly (RGD
Peptide, GL Biochem), 1,ĺ-carbonyldiimidazole (CDI, GL Biochem), nerve growth factor
(NGF, Sigma, 7S NGF), 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDAC,
Aldrich), other reagents were all of analytical grade. Wistar rats were purchased from
Tongji Medicinal School, Huazhong University of Technology.
RGD peptide modification of PLGL
PLGL (2.5g) was dissolved in 50 ml of dichloromethane. RGD Peptide (50 mg) was dis-
solved in 20 ml of dimethyl sulfoxide and added to the resulting solution. CDI (42.5 mg)
dissolved in 1 ml of dichloromethane was added to the mixture solution. The reaction
mixture was stirred for 4 h. After removal of dichloromethane in vacuum, methanol was
added to complete copolymer precipitation. The precipitate was dried under high vacuum.
NGF modification of PLGL-RGD membranes
PLGL-RGD was dissolved in ethyl acetate at a concentration of 10wt%. PLGL-RGD
membranes were prepared using the solvent evaporation method. PLGL-RGD mem-
branes were soaked in 20 mL EDAC solution with a concentration of 1mg/mL for 24h
at 4°C. Unbound and excess EDAC was removed by washing the membranes with
double-distilled water. The membranes were then transferred to 10 mL NGF solution
with different concentration of 10, 25, 40 and 50ng/mL for 24 h at 4°C. The unbound
NGF was removed by washing the membranes with the phosphate buffer solution
(PBS, pH=7.4). After NGF was immobilized on PLGL-RGD membranes, the soaking
solution and the phosphate buffer solution were collected and the amout of NGF of
these solution was measured by ELISA. The amount of NGF immobilized on the
PLGL-RGD membrane could be calculated by that the total NGF in the soaking solu-
tion for immobilization subtracted by the amount of uncross-linked NGF.
Preparation of PLGL-RGD–NGF, PLGL-RGD and PLGL nerve conduits
The side containing NGF of PLGL-RGD–NGF membranes were rolled in an inside of a
conduit, while the opposite side of them were sealed to fabricate the PLGL-RGD–NGF
conduits. PLGL membranes were prepared using the solvent evaporation method.
PLGL and PLGL-RGD membranes were rolled to fabricate PLGL and PLGL-RGD con-
duits. The final length of nerve conduits was 14 mm, with an inner diameter of 2.0 mm
and a tube wall thickness of 0.2 mm. All membranes or nerve conduits were sterilized
with ultraviolet light for the later experiment.
Cell culture
Schwann cells from neonatal Wistar rats were isolated and expanded in culture using
methods described by Honkanen H et al. [29].
Schwann cells were seeded on PLGL-RGD–NGF,PLGL-RGD and PLGL membranes
at a density of 1 × 106 cells/cm2, incubated in a humidified incubator at 37°C and 5%
CO2. On day 5, the membranes with cells attached were washed three times with PBS
and then fixed with 3.7% formaldehyde for 30 min, and washed again with PBS. The
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washed three times with PBS, the cells were stained with Hoechst 33258 for 10 min
and photographed using a laser confocal microscope.
Cell viability on the membranes was characterized by MTT assay. PLGL-RGD–NGF,
PLGL-RGD and PLGL membranes were cut into small circular pieces with a diameter
of 6.38 mm and placed in a 96-well culture plate. Schwann cells were seeded in 96 well
culture plates at a density of 1 × 105 cells/well, incubated in a humidified incubator at
37°C and 5% CO2. After culturing for 1 day, 3 days and 5 days respectively, the super-
natant was removed. 20 μL MTT solution (5 mg/mL) was added to each culture well
and incubated for 4 h. The absorbance at 490 nm was recorded by an automatic en-
zyme scanner. Five parallels for every sample were averaged.
Animals and surgical procedure
All procedures undertaken in this study were approved by the Animal Care and Use
Committees of Wuhan university of technology and conformed to NIH guidelines.
Thirty-two male Wistar rats were randomized into 4 groups, 8 weeks old at the be-
ginning of the experiments, 8 rats each: group PLGL-RGD-NGF, group PLGL-RGD,
group PLGL and group autograft. The rats were anesthetized with 40mg/kg pentobar-
bital sodium. The right sciatic nerve was exposed after skin incision, and separation of
muscles around the nerve tissues using blunt dissection. Subsequently, the right sciatic
nerve was severed into proximal and distal segments in the middle of the right thigh.
Defects of 10 mm in the sciatic nerve were created by surgical removal of the nerve
tissue. Both the proximal and the distal stumps were secured with 9-0 nylon to a depth
of 2 mm into the conduits, leaving a 10 mm gap between the stumps in groups PLGL-
RGD-NGF, PLGL-RGD and PLGL. In group autograft, the nerve defect was bridged
with the resected nerve segment, which was reversed and anastomosed to the proximal
and distal nerve stumps. The wound was closed in two layers with 6-0 nylon sutures.
Footprint analysis
After dipping the hind feet in carbon ink, the rat was placed in a paper-lined walkway
(8 × 42 cm) that led into a darkened cage [30]. Footprints left on the paper as the rat
walked down the track.
The footprints were measured according to three parameters: (i) distance from the
heel to the third toe, the print length (PL), (ii) distance from the first to the fifth toe, the
toe spread (TS), and (iii) distance from the second to the fourth toe, the intermediate
toe spread (ITS). The data were used to compute: (i) print length factor (PLF) = (EPL-
NPL)/NPL, (ii) toe spread factor (TSF) = (ETS-NTS)/NTS, and (iii) intermediary toe
spread factor (ITSF) = (EITS-NITS)/NITS, where E is for the experimental side and N is
for the normal control. These factors were adapted to the Bain-Mackinnon-Hunter sci-
atic function index (SFI) [31] by the formula,
SFI ¼ 38:3 PLFþ 109:5 TSFþ 13:3 ITSF8:8
Electrophysiologic assessment
At 3 months after surgery, electrophysiologic tests were performed on all animals. Ani-
mals were anesthetized with sodium pentobarbital, the previous surgical site was reo-
pened, and the sciatic nerve was re-exposed. Single electrical pulses were delivered via
bipolar electrodes placed in turn at the proximal and distal trunk of the grafted nerve.
Compound muscle action potentials (CMAPs) were recorded via an electrode inserted
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the distance between the proximal and distal sites of stimulation was measured for the
determination of the conduction velocity across the regenerated nerve.
Histological evaluation
The implanting conduits were harvested immediately after the electrophysiologic tests.
The nerve specimens were fixed in 4% glutaraldehyde for 24 h. The regenerated nerve
stumps in the proximal and distal directions were removed. The 5mm middle segments
of the regenerated nerves in each group were embedded with olefin and then cut into
4-μm thickness for H and E staining and S-100 immunohistochemistry analysis. Other
5mm middle segments of the regenerated nerves in each group were embedded with
epoxy resin. The thin–thick slices of 1.0 μm were made and stained with methylene
blue. All the nerve sections were observed under a light microscope. To minimize the
error, at 400 ×magnification, six measurement windows were randomly selected by an
observer blinded to the experiment to count each nerve, using HPIAS-1000 high-
resolution color graphic report of the pathology analysis system to analyze the photo-
graphs for the determination of the myelinated axon density, myelin thickness, and the
diameter of axons of the regenerated nerve. Analysis of the digitalized information,
based on gray and white scales, was performed by the computer software. Axons were
identified by the deeply stained color. A total area of myelinated fibers was measured
for each nerve specimen. Thickness of axon sheaths on cross section was also mea-
sured by the morphometric computer software. The ultrathin slices of 50 nm were
made and stained with lead citrate and uranylacetate, and then were examined under a
transmission electron microscope (Tecnai, FEI).
Statistical analysis
Experimental data were processed using the statistical software SPSS 10.0 (Bizinsight,
Beijing China), and expressed as mean ± standard error of mean. Statistical differences
were analyzed using single-factor analysis. The means of the two groups were com-
pared using least significant difference law (α= 0.05).Results
RGD peptide modification
It was reported that peptides could be attached to poly(lactic acid-co-lysine) using CDI
as a linking agent [32]. In the present work, we used the same method to couple RGD
peptide to PLGL. Amino acid analysis (AAA) demonstrated that RGD peptide was
coupled to the copolymer at a concentration of 9.2-17.3 μmol/g.NGF immobilization
In the study, the NGF solution of different concentration was used to immobilize NGF
molecules on PLGL-RGD membranes. As shown in Figure 1, the number of NGF immo-
bilized on PLGL-RGD membranes was increasing from 6.85 ng/cm2 to 27.6 ng/cm2 with
the NGF concentration of the soaking solution.Cell culture
As shown in Figure 2, the OD value of each test group increased with the cultured
time. At the first day, the OD values of group PLGL-RGD-NGF were similar to group
Figure 1 The amount of NGF immobilized on PLGL-RGD-NGF membranes (n = 5).
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was higher than that of group PLGL-RGD (P< 0.05). From day 1 to day 5, the OD
values of groups PLGL-RGD-NGF and PLGL-RGD were higher than that of group
PLGL (P< 0.05). As shown in Figure 3, Schwann cells on PLGL-RGD-NGF and
PLGL-RGD membranes also adhered and extended better than those on PLGL mem-
branes. Schwann cells on PLGL-RGD-NGF membrane appeared with a characteristic
spindle shape.Figure 2 The viability of schwann cells seeded on PLGL, PLGL-RGD and PLGL-RGD-NGF membranes
assayed by MTT on days 1, 3 and 5 respectively (*p<0.05, **p> 0.05).
Figure 3 Schwann cells morphology cultured on the different membranes for 5 days. A: PLGL
membrane, B: PLGL-RGD membrane, C: PLGL-RGD-NGF membrane.
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The SFI value was calculated in only 26 rats because of automutilations and paw con-
tractions. There was no significant difference between the four groups at the beginning
1 month. But 1 month later, the SFI value of groups PLGL-RGD-NGF and autograft
was significantly higher than the other groups (p< 0.05). The SFI value of group
PLGL-RGD-NGF was similar to that of group autograft (p> 0.05, Figures 4 and 5).Electrophysiologic assessment
At 3 months after surgery, CMAPs were detected in all groups on the side bearing the
bridged sciatic nerve. Based on latencies of the CMAPs, nerve conduction velocities
(NCVs) were determined (Figure 6). The NCVs of group PLGL-RGD-NGF were signifi-
cantly faster than those of groups PLGL-RGD and PLGL (P< 0.05). The NCVs of
group PLGL-RGD-NGF was similar to those of group autograft (P> 0.05).Histological assessment
At 3 months after surgery, the regenerated nerve had grown cross through the 10 mm
gap. H and E staining (Figure 7), methylene blue staining (Figure 8), and lead citrate
Figure 4 Sciatic function indices of all animal groups (*p<0.05, **p> 0.05).
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of each group. For group PLGL-RGD-NGF, the regenerated nerve fibers dispersed
densely and the myelinated fibers had a compact and uniform structure including clear
electron-dense myelin sheath and perfect basal membrane of Schwann cells. In
addition, statistical analysis revealed that there was no significant difference in the
morphometric data, including the density of myelinated fibers, the mean diameter of
myelinated fibers and the average thickness of myelin sheath, between groups PLGL-
RGD-NGF and autograft (p> 0.05). The density of myelinated fibers, the mean diameter
of axon and the average thickness of myelin sheath in group PLGL-RGD-NGF were sig-
nificantly higher than those in groups PLGL-RGD and PLGL (p< 0.05) (Figures 10, 11
and 12). Consistent with the the result of cell culture, the S-100 positive expression of
group PLGL-RGD-NGF was the strongest compared with groups PLGL-RGD and PLGL
(p< 0.05). The S-100 positive expression of group PLGL-RGD was stronger than that of
group PLGL (p< 0.05) (Figures 13 and 14).Discussion
Transection is one of the most severe injuries in the peripheral nerve. Although periph-
eral nerves have the potential for regenerating after injury, this capacity is strictly de-
pending on the microenvironment for regeneration. At present there are a few
synthetic nerve conduits approved by FDA and CE for clinical nerve repair. These are
rudimental conduits that act as a guide for the regenerating axons and as a barrier
against the ingrowth of scar-forming tissue. However physical nerve guidance by them
may not be sufficient to foster optimal nerve regeneration and functional recovery.
NGF is also required in the treatment of peripheral nerve injury to ensure the survival
of the cell bodies and to support the regeneration of the axons toward specific target
organs. However NGF supplementation alone is insufficient for substantive axonal
Figure 5 The rats’ walking track of different groups at 3 months after surgery. A: group PLGL, B:
group PLGL-RGD, C: group PLGL-RGD-NGF, D: group autograft, E: normal group.
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indispensable role in supporting axonal regrowth. Therefore, we modified PLGL with
RGD peptide and NGF to fabricate new PLGL-RGD-NGF nerve conduits.
A very small concentration of RGD peptides was shown to have enhanced biological
effects, for instance, nonadherent surface on incorporation of 1 fmol/cm2 of an RGD
peptide concentration effectively promoted cell adhesion [32]. In this study, we pre-
pared PLGL-RGD membranes containing 9.2-17.3 μmol/g RGD peptide. Cell culture
showed that Schwann cells on PLGL-RGD-NGF and PLGL-RGD membranes exhibited
significantly higher total viability than those on PLGL membranes from day 1 to day 5
(P< 0.05) (Figure 2). These demonstrated that RGD peptide of PLGL-RGD-NGF and
PLGL-RGD membranes could effectively enhance Schwann cells adhesion. Interest-
ingly, from day 3 to day 5, Schwann cells on PLGL-RGD-NGF membranes also exhib-
ited higher viability than those on PLGL-RGD membranes (Figure 2). This could be
due to cell adhesion molecule expression on Schwann cells which can be directly regu-
lated by NGF of PLGL-RGD-NGF membranes [33].
NGF has been shown to enhance neuron survival and stimulate nerve regeneration.
However, NGF has a short half-life in the body. In order to prolong the availability of
NGF to targeted tissues, we immobilized NGF on the nerve conduits with EDAC. The
Figure 6 Nerve conduction velocities in groups PLGL, PLGL-RGD, PLGL-RGD-NGF and autograft
(*p<0.05, **p> 0.05).
Figure 7 Hematoxylin/eosin staining of the regenerated nerves in different groups at 3 months
after surgery. Scale Bar: 200μm. A: group PLGL, B: group PLGL-RGD, C: group PLGL-RGD-NGF, D: group
autograft.
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Figure 8 Regenerated nerve stained with methylene blue in different groups at 3 months after
surgery. Scale Bar: 50μm. A: group PLGL, B: group PLGL-RGD, C: group PLGL-RGD-NGF, D: group autograft.
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the surface of PLGL-RGD membranes reacting with the amine groups of NGF in the
presence of EDAC. The amount of NGF immobilized on PLGL-RGD membranes was
concerned with not only the NGF concentration of the soaking solution but also the
number of the carboxyl groups on the surface of PLGL-RGD membranes. Because
Bhang SH et al. reported that 100 ng/mL immobilized NGF could effectively enhance
cell viability, mitochondrial metabolic activity, and neuronal differentiation. Moreover,
cell viability, mitochondrial metabolic activity, and neuronal differentiation signaling
due to immobilized NGF could be sustained for longer periods than by NGF added to
culture medium [34]. In the present study, we only choosed 10ng/mL NGF to modify
PLGL-RGD membranes. There was about 6.85 ng/cm2 of NGF grafted on the PLGL-
RGD membranes. In this context, PLGL-RGD-NGF nerve conduits (2 mm diameter ×
14 mm length) contained about 137 ng/mL NGF. If we choosed 50 ng/mL NGF to
modify PLGL-RGD membranes. There was about 27.6 ng/cm2 of NGF grafted on the
PLGL-RGD membranes. PLGL-RGD-NGF nerve conduits (10mm diameter) also con-
tained about 110.4 ng/mL NGF. Therefore, by selecting different NGF concentration,
PLGL-RGD-NGF nerve conduits of different sizes should contain enough NGF to pro-
mote neural cell growth and differentiation.
SFI is a simple and repeatable method for evaluating the functional condition of sci-
atic nerve injuries. A straightforward measure of muscle innervation is the amplitude
of CMAPs following electrical stimulation of the nerve. The muscles to be assessed can
be defined, and the technique is easily applicable to rats [35]. But considerable
Figure 9 Transmission electron microscope images of the regenerated nerve in different groups at
3 months after surgery. A: group PLGL, B: group PLGL-RGD, C: group PLGL-RGD-NGF, D: group autograft.
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even with supramaximal stimulation intensities. Therefore, in this study, the amplitude
of CMAPs was not used for assessment of the functional recovery of the sciatic nerves.
Rather, the latency for eliciting CMAPs was used for the determination of conductionFigure 10 The density of myelinated fibers in groups PLGL, PLGL-RGD, PLGL-RGD-NGF and
autograft (*p<0.05, **p> 0.05).
Figure 11 The mean diameter of axon in groups PLGL, PLGL-RGD, PLGL-RGD-NGF and autograft
(*p<0.05, **p> 0.05).
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been completely destroyed. The SFI value dramatically decreased and NCV could not
be detected at the first month after the operation. At 3 months after surgery, the SFI
value and NCV of groups PLGL-RGD-NGF and autograft were significantly higher
than those of groups PLGL-RGD and PLGL. The SFI value and NCV of group PLGL-
RGD-NGF were similar to that of group autograft. These showed that functional
recovery of groups PLGL-RGD-NGF and autograft were quicker and superior than that
of groups PLGL-RGD and PLGL.Figure 12 The average thickness of myelin sheath in groups PLGL, PLGL-RGD, PLGL-RGD-NGF and
autograft (*p<0.05, **p> 0.05).
Figure 13 The immunocytochemical staining of S-100 of the regenerated nerves in different groups
at 3 months after surgery. Scale Bar: 50μm. A: group PLGL, B: group PLGL-RGD, C: group PLGL-RGD-NGF.
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expression in group PLGL-RGD-NGF than that of groups PLGL-RGD and PLGL.
Histological assessment showed that the density of myelinated fibers, the mean diam-
eter of axon and the average thickness of myelin sheath in group PLGL-RGD-NGFFigure 14 The statistical analysis of S-100 positive area of the regenerated nerve in groups PLGL,
PLGL-RGD and PLGL-RGD-NGF (*p<0.05).
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PLGL-RGD and PLGL. These showed that PLGL-RGD-NGF nerve conduits could ef-
fectively enhance Schwann cells adhesion and migration, axonal growth and the matur-
ity of regenerated myelin sheaths.
Conclusion
New PLGL-RGD-NGF nerve conduits were fabricated by grafting RGD peptides and
NGF on PLGL to promote nerve regeneration and functional recovery. The results of
cell culture showed that PLGL-RGD-NGF more efficiently enhanced Schwann cells ad-
herence and growth than PLGL. For a 10mm defect in the rat sciatic nerve, nerve re-
generation and functional recovery of PLGL-RGD-NGF nerve conduits performed
similar to autograft and better than PLGL nerve conduits. This work established the
platform for further development of the use of PLGL-RGD-NGF nerve conduits for
clinical nerve repair.
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